| |
| |
|
| Insider
Information: |
Thomas Paul |
| Relationship: |
Director |
| City: |
Branchburg |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
145,672 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$65,136 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
145,672 |
|
|
| Total
Value |
$65,136 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Lifecell Corp |
LIFC |
Chairman, President an... |
2008-05-19 |
0 |
2004-12-15 |
0 |
Premium* |
|
|
Avanir Pharmaceuticals |
AVNR |
Director |
2007-03-01 |
50,683 |
2006-02-13 |
0 |
Premium* |
|
|
Kinetic Concepts Inc |
KCI |
President, LifeCell Co... |
2008-08-25 |
0 |
|
0 |
Premium* |
|
|
Orthovita Inc |
VITA |
Director |
2011-06-27 |
0 |
2008-07-17 |
0 |
Premium* |
|
|
ABIOMED Inc |
ABMD |
|
2022-12-22 |
0 |
2012-08-08 |
0 |
Premium* |
|
|
Roka Bioscience, Inc. |
ROKA |
President and CEO, Dir... |
2016-11-10 |
85,494 |
|
0 |
Premium* |
|
|
Aegerion Pharmaceuticals, Inc. |
AEGR |
Director |
2016-11-29 |
0 |
2016-11-29 |
0 |
Premium* |
|
|
Axogen Inc |
AXGN |
Director |
2023-06-01 |
9,495 |
2022-06-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
109 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LIFC |
Lifecell Corp |
Chairman, President and CEO |
• • – |
2008-01-04 |
4 |
D |
$43.70 |
$1,989,093 |
D/D |
(45,517) |
256,470 |
0 |
- |
|
| LIFC |
Lifecell Corp |
Chairman, President and CEO |
• • – |
2008-05-19 |
4 |
D |
$51.00 |
$9,597,894 |
D/D |
(188,194) |
0 |
0 |
- |
|
| ROKA |
Roka Bioscience, Inc. |
President and CEOOfficer |
• • – |
2014-07-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
783,512 |
|
- |
|
| ROKA |
Roka Bioscience, Inc. |
President and CEO |
• • – |
2016-11-10 |
4 |
OE |
$7.00 |
$50,001 |
D/D |
7,143 |
85,494 |
0 |
- |
|
| VITA |
Orthovita Inc |
Director |
– • – |
2008-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
4,700 |
4,700 |
0 |
- |
|
| VITA |
Orthovita Inc |
Director |
– • – |
2009-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
4,700 |
4,700 |
0 |
- |
|
| VITA |
Orthovita Inc |
Director |
– • – |
2010-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
4,700 |
4,700 |
0 |
- |
|
| VITA |
Orthovita Inc |
Director |
– • – |
2011-06-24 |
4 |
D |
$3.85 |
$24,128 |
D/D |
(6,267) |
7,833 |
0 |
- |
|
| VITA |
Orthovita Inc |
Director |
– • – |
2011-06-27 |
4 |
D |
$3.85 |
$30,157 |
D/D |
(7,833) |
0 |
0 |
- |
|
109 Records found
|
|
Page 5 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
